JENNIFER MAY: Open Payments
NPI 1295396943 · CLAYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 36 payments from 12 companies in 2025. Trend: 2023 $921 · 2024 $542 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $176 |
| PFIZER INC. | 10 | $166 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Lilly USA, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: PREVNAR 20, ELIQUIS, Rybelsus, QULIPTA, Ozempic, TRELEGY ELLIPTA, Auvelity, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
